Congen Biotechnologie GmbH
Congen Biotechnologie GmbH is a Private limited company (Ltd.) registered in Germany under HRB 66245 B Charlottenburg (Berlin), and its current status with Handelsregister (Commercial Register) is active. The company was incorporated on 14 January 1998 and lists its registered address as Berlin, Germany. 2 shareholders are on record for Congen Biotechnologie GmbH, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 28 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Two shareholders are currently on record for Congen Biotechnologie GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG.
The largest of these is R- Biopharm AG, holding 85% — a majority holding — followed by Steffen Mergemeier at 15%.
1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| R- Biopharm AG | 85% | Handelsregister (Commercial Register) | |
| Steffen Mergemeier | 15% | Handelsregister (Commercial Register) |
Officers
2
One of the 2 officer records shown for Congen Biotechnologie GmbH is a current appointment, filed with Handelsregister (Commercial Register). Steffen Mergemeier (appointed 2004-09-09) serves as Geschäftsführer (managing director). The remaining 1 record shown (Matthias Kuhn) is a former appointment that has since been resigned.
Management authority at Congen Biotechnologie GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Congen Biotechnologie GmbH sits 1 level below its ultimate parent, R-Biopharm AG, registered in Germany. The full chain up to R-Biopharm AG is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Congen Biotechnologie GmbH's own shareholder record.
R-Biopharm AG
Germany
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Congen Biotechnologie GmbH?
Two shareholders are currently on record for Congen Biotechnologie GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is R- Biopharm AG, holding 85% — a majority holding — followed by Steffen Mergemeier at 15%. 1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is Congen Biotechnologie GmbH's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Congen Biotechnologie GmbH is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Congen Biotechnologie GmbH have on record?
2 shareholders are shown on record for Congen Biotechnologie GmbH.
What is Congen Biotechnologie GmbH's company registration number?
Congen Biotechnologie GmbH's registration number is HRB 66245 B Charlottenburg (Berlin), filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is Congen Biotechnologie GmbH still an active company?
Congen Biotechnologie GmbH's status on Handelsregister (Commercial Register) is listed as active.
When was Congen Biotechnologie GmbH incorporated?
Congen Biotechnologie GmbH was incorporated on 14 January 1998, according to Handelsregister (Commercial Register).
What is Congen Biotechnologie GmbH's registered address?
The registered address on file for Congen Biotechnologie GmbH is Berlin, Germany.
Who are the officers/directors of Congen Biotechnologie GmbH?
One of the 2 officer records shown for Congen Biotechnologie GmbH is a current appointment, filed with Handelsregister (Commercial Register). Steffen Mergemeier (appointed 2004-09-09) serves as Geschäftsführer (managing director). The remaining 1 record shown (Matthias Kuhn) is a former appointment that has since been resigned. Management authority at Congen Biotechnologie GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Congen Biotechnologie GmbH have a parent company or subsidiaries?
Congen Biotechnologie GmbH sits 1 level below its ultimate parent, R-Biopharm AG, registered in Germany.
Can Zavia monitor changes to Congen Biotechnologie GmbH's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to Congen Biotechnologie GmbH's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Congen Biotechnologie GmbH's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like Congen Biotechnologie GmbH's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 28 October 2026.